Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.45 |
| ▸ | ERN1 | O75460 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.41 |
| ▸ | MITF | O75030 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | CCR6 | P51684 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | TRIM24 | O15164 | 2/20 | 0.39 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29392367 | 0.91 | ALDH1A1 (0.50) | MEN1KMT2ALMNATHRBBLM | |
| SCHEMBL39718 | 0.91 | ALDH1A1 (0.50) | MEN1KMT2ALMNATHRBBLM | |
| SCHEMBL30446471 | 0.89 | ALDH1A1 (0.49) | MEN1KMT2ALMNATHRBBLM | |
| SCHEMBL548781 | 0.89 | ALDH1A1 (0.49) | MEN1KMT2ALMNATHRBBLM | |
| SCHEMBL548710 | 0.89 | ALDH1A1 (0.49) | MEN1KMT2ALMNATHRBBLM | |
| SCHEMBL31340003 | 0.89 | ALDH1A1 (0.49) | MEN1KMT2ALMNATHRBBLM | |
| SCHEMBL7036744 | 0.88 | MEN1 (0.46) | MEN1KMT2ALMNATHRBBLM | |
| SCHEMBL5746410 | 0.88 | ALDH1A1 (0.42) | MEN1KMT2ALMNATHRBBLM | |
| Methyl Alcohol SCHEMBL27597852 | 0.86 | ALDH1A1 (0.46) | MEN1KMT2ALMNATHRBBLM | |
| SCHEMBL31317593 | 0.85 | ERN1 (0.43) | MEN1KMT2ALMNATHRBBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120056488-A | Preparation method of copper-free and steel-free carbon fiber composite friction plate applied to electric bicycle | 浙江万赛汽车零部件股份有限公司 | 2025-05-30 | — | — | CN | disclosed |
| US-10392395-B2 | Nitrogen-containing aromatic compounds and metal complexes | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-08-27 | — | — | US | disclosed |
| US-10392395-B2 | Nitrogen-containing aromatic compounds and metal complexes | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-08-27 | — | — | US | disclosed |
| EP-2493890-B1 | NITROGEN-CONTAINING AROMATIC COMPOUNDS AND METAL COMPLEXES | SUMITOMO CHEMICAL CO (JP) | 2018-03-21 | — | — | EP | disclosed |
| CN-102666547-B | Nitrogen-containing aromatic compound and metal complex | SUMITOMO CHEMICAL CO.,LTD. (JP) | 2016-05-04 | — | — | CN | disclosed |
| US-8993806-B2 | Organic porous materials comprising shape-persistent three-dimensional molecular cage building blocks | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2015-03-31 | — | — | US | disclosed |
| US-8993806-B2 | Organic porous materials comprising shape-persistent three-dimensional molecular cage building blocks | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2015-03-31 | — | — | US | disclosed |
| US-20130047849-A1 | Organic Porous Materials Comprising Shape-Persistent Three-Dimensional Molecular Cage Building Blocks | THE REGENTS OF THE UNIVERSITY OF COLORADO | 2013-02-28 | — | — | US | disclosed |
| US-20130047849-A1 | Organic Porous Materials Comprising Shape-Persistent Three-Dimensional Molecular Cage Building Blocks | THE REGENTS OF THE UNIVERSITY OF COLORADO | 2013-02-28 | — | — | US | disclosed |
| US-20120270141-A1 | NITROGEN-CONTAINING AROMATIC COMPOUNDS AND METAL COMPLEXES | MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2012-10-25 | — | — | US | disclosed |
| WO-2011052805-A1 | NITROGEN-CONTAINING AROMATIC COMPOUNDS AND METAL COMPLEXES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-05-05 | — | — | WO | disclosed |
| US-6610663-B2 | Antisense compound with targeting and RNA cleaving moieties, preferably an imidazole functionality conjugated to the targeting oligonucleotide via linkers | ISIS PHARMACEUTICALS, INC. | 2003-08-26 | — | — | US | disclosed |
| US-20020160972-A1 | Compositions and methods for modulating RNA | ISIS PHARMACEUTICALS, INC. | 2002-10-31 | — | — | US | disclosed |
| US-6358931-B1 | OLIGONUCLETIDE CONJUGATED TO IMIDAZOLE; INTERCALATION AND COORDINATION COMPOUNDS; MEDICAL DIAGNOSIS, GENE THERAPY; ANTISENSE AGENTS | ISIS PHARMACEUTICALS, INC. | 2002-03-19 | — | — | US | disclosed |
| EP-0656790-A1 | COMPOSITIONS AND METHODS FOR MODULATING RNA | ISIS PHARMACEUTICALS, INC. (US) | 1995-06-14 | — | — | EP | disclosed |
| WO-1993017717-A1 | COMPOSITIONS AND METHODS FOR MODULATING RNA | ISIS PHARMACEUTICALS, INC. (US) | 1993-09-16 | — | — | WO | disclosed |
| EP-0041675-B1 | 4-HALOGEN-5-(TRICHLOROMETHYL-PHENYL)-OXAZOLE DERIVATIVES, PROCESS FOR PREPARING THEM AND RADIATION-SENSITIVE COMPOSITIONS CONTAINING THEM | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-12-11 | — | — | EP | disclosed |
| US-4371607-A | 4-Halogeno-5-(halogenomethyl-phenyl)-oxazole derivatives, a process for the preparation thereof, and radiation-sensitive compositions containing these derivatives | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-02-01 | — | — | US | disclosed |
| EP-0041675-A2 | 4-Halogen-5-(trichloromethyl-phenyl)-oxazole derivatives, process for preparing them and radiation-sensitive compositions containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-12-16 | — | — | EP | disclosed |
| US-4017313-A | Photosensitive composition containing a leuco dye, a photosensitizer, an aromatic aldehyde and a secondary or tertiary amine and the use thereof in a direct-print process | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020160972-A1 | Compositions and methods for modulating RNA | RNGTT, NSUN3, NSUN2 | MEN1 3459/4885KMT2A 1080/4885LMNA 375/4885 |
| US-20120270141-A1 | NITROGEN-CONTAINING AROMATIC COMPOUNDS AND METAL COMPLEXES | TYR, MT-CO2, SOD1 | MEN1 2740/4885KMT2A 1041/4885LMNA 3383/4885 |
| US-10392395-B2 | Nitrogen-containing aromatic compounds and metal complexes | TYR, MT-CO2, SOD1 | MEN1 2740/4885KMT2A 1041/4885LMNA 3383/4885 |
| US-20130047849-A1 | Organic Porous Materials Comprising Shape-Persistent Three-Dimensional Molecular Cage Building Blocks | CAPG, NCBP1, ORC3 | MEN1 4578/4885KMT2A 4326/4885LMNA 3567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.